Skip to content

Viewray System

by Viewray Incorporated

510(k) K111862

Viewray System is a Class II device made by Viewray Incorporated, cleared under FDA 510(k) K111862 on 22 May 2012, active as of 22 Oct 2026. 9 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

9 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK111862 Date22 May 2012ClearedStatusActive

Official records

Recalls

9 recalls · FDA

    • Terminated Z-0481-2021 FDA Class II initiated 20 Oct 2020

    There is a potential that components of the receive coil can reach elevated temperatures which has the potential to cause a burn injury to the patient or user.

    • Terminated Z-1803-2020 FDA Class II initiated 18 Nov 2019

    Registering dose and structures in the treatment delivery workflow could result in an alignment discrepancy between the imported previously delivered dose and the displayed patient anatomy and structures. The MRIdian TPDS software shows this misalignment to the user in the predicted dose-volume histogram (DVH). The misalignment impact may not be obvious to the user. During plan re-optimization the previously delivered dose would be incorrectly accounted for by the software. This may result in unexpectedly higher or lower dose than the intended dose calculated for the subsequent treatment plan. When this occurs in the treatment planning workflow, the registration fails to align the dose with the image and the user is unable to proceed.

    • Terminated Z-0676-2020 FDA Class II initiated 3 Mar 2019

    Issue with transferring treatment regiment from one system to another. Adequate instructions for transferring treatment plan(s) are not provided within the operator's manual or within the software operating system.

    • Terminated Z-1309-2016 FDA Class II initiated 7 Mar 2016

    When editing the isocenter or the couch position of the plan while in the treatment workflow (in the Points screen) and re-optimizing, the software will not prompt the user to shift the couch to the new isocenter. As a result there is the potential to deliver dose to the initial isocenter rather than the new location.

    • Terminated Z-0806-2016 FDA Class II initiated 24 Dec 2015

    The system loaded a completion fraction in the incorrect order after a treatment interruption.

    • Terminated Z-0115-2016 FDA Class II initiated 27 Aug 2015

    ViewRay discovered that in the event that an encoder breaks or fails on the Patient Handling System (PHS, or couch), when attempting to restart the system, the couch could move unexpectedly.

    • Terminated Z-1954-2015 FDA Class II initiated 7 May 2015

    The software was failing to determine new patient locations if imaging is not enabled during treatment.

    • Terminated Z-2085-2015 FDA Class II initiated 1 Apr 2015

    ViewRay received a report that the couch moved unexpectedly into the bore after performing a RTCS reboot.

    • Terminated Z-1580-2015 FDA Class II initiated 15 Jan 2015

    The software was not correctly using the RT (Radiation Therapy) to MR (Magnetic Resonance image) coordinate correction for non HFS (Head First Supine) patient orientations, resulting in slice mismatch error.

Timeline

10 dated events

  1. Cleared FDA 510(k) K111862
  2. Recall initiated FDA recalls Z-1580-2015
  3. Recall initiated FDA recalls Z-2085-2015
  4. Recall initiated FDA recalls Z-1954-2015
  5. Recall initiated FDA recalls Z-0115-2016
  6. Recall initiated FDA recalls Z-0806-2016
  7. Recall initiated FDA recalls Z-1309-2016
  8. Recall initiated FDA recalls Z-0676-2020
  9. Recall initiated FDA recalls Z-1803-2020
  10. Recall initiated FDA recalls Z-0481-2021

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
IYE
FDA applicant
Viewray, Incorporated
Device class
Class II
Regulation
21 CFR Part 892.5050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code IYE (Accelerator, Linear, Medical).

Other devices from Viewray Incorporated

See all devices from Viewray Incorporated →